We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA批准efgartigimod（Vyvgart）用于所有血清型的全身型重症肌无力，包括血清阴性患者。了解这将如何改变市场及其对您的意义。阅读详细分析。
